Education
About Us
Working with TipRanks
Follow Us
Corey Michael Watton Insider Profile
4 Followers
Corey Michael Watton, Director at Zevra Therapeutics, holds 1.80K shares in Zevra Therapeutics (Ticker: ZVRA). Most recently, Corey Michael Watton Bought $300 shares of Zevra Therapeutics on Mar 31, 2025 for an estimated value of 2.35K.
Corey Michael Watton Zevra Therapeutics (ZVRA)Director
Zevra Therapeutics (ZVRA)
Director
Ranked #26,248 out of 102,674 Corporate Insiders
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
+10.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Corey Michael Watton's holdings
Insider Roles
Director
Roles that Corey Michael Watton holds in companies
Most Profitable Insider Trade
The most profitable trade made by Corey Michael Watton
Corey Michael Watton's Trading History
List of latest transactions for each holding click on a transaction to see Corey Michael Watton's performance on stock
You May Also Like
Corey Michael Watton insider profile FAQ
What is the percentage of profitable transactions made by Corey Michael Watton?
The percentage of profitable transactions made by Corey Michael Watton is 40%.
What is the average return per transaction made by Corey Michael Watton?
The average return per transaction made by Corey Michael Watton is 10.50%.
What stocks does Corey Michael Watton hold?
Corey Michael Watton holds: ZVRA stocks.
What was Corey Michael Watton’s latest transaction?
Corey Michael Watton latest transaction was an Informative Buy of $2.35K.
What was Corey Michael Watton's most profitable transaction?
Corey Michael Watton’s most profitable transaction was an Informative Buy of ZVRA stock on March 31, 2025. The return on the trade was 49.90%.
What is Corey Michael Watton's role in Zevra Therapeutics?
Corey Michael Watton's role in Zevra Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.